Monogram Health Revenue and Competitors

Location

#429

Growjo Ranking

Estimated Revenue & Valuation

  • Monogram Health's estimated annual revenue is currently $192.4M per year.(i)
  • Monogram Health's estimated revenue per employee is $342,900
  • Monogram Health's total funding is $172M.

Employee Data

  • Monogram Health has 561 Employees.(i)
  • Monogram Health grew their employee count by 14% last year.

Monogram Health's People

NameTitleEmail/Phone
1
Product Owner, Technology Platforms for Member ServicesReveal Email/Phone
2
Chief Clinical OfficerReveal Email/Phone
3
Chief Legal Officer and SecretaryReveal Email/Phone
4
Chief Human Resources OfficerReveal Email/Phone
5
CEO & Co-FounderReveal Email/Phone
6
Chief StaffReveal Email/Phone
7
Data Science VPReveal Email/Phone
8
Chief Staff, FinanceReveal Email/Phone
9
Chief Staff to Chief Legal OfficerReveal Email/Phone
10
VP, Senior Associate General CounselReveal Email/Phone
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$18.2M751%N/AN/A
#2
$938.2M24829%N/AN/A
#3
$8.9M413%N/AN/A
#4
$112.4M333N/AN/AN/A
#5
$17.5M7216%N/AN/A
#6
$1067.9M28253%N/AN/A
#7
$22.4M838%N/AN/A
#8
$266.1M704-4%N/AN/A
#9
$112.4M3333%N/AN/A
#10
$61.8M208-1%N/AN/A
Add Company

What Is Monogram Health?

Our name, Monogram, symbolizes the personalized focus of our services. While the application of the latest technology and data science is critical to our success, we never lose sight that healthcare is ultimately about trusted individual relationships between healthcare professionals and their patients. Unfortunately, individuals living with advanced CKD and ESRD are negatively impacted by well entrenched systematic forces such as perverse economic incentives, poor adherence to evidence-based care, and a lack of sensitivity to the negative impacts of social determinants of health. The 21st Century Cures Act is a seminal piece of legislation designed to shift individuals living with ESRD from FFS Medicare into managed care and reverse decades and decades of sub-optimal outcomes. Monogram was born with a vision to serve health plans and other sponsors of health care and solve for these systemic problems. Our mission is to improve clinical outcomes by predicting the onset of CKD and ESRD, slowing its progression, and reducing hospitalizations, morbidity and mortality. We are founded and operated by a core group of former government programs health plan executives, including our CEO, Michael Uchrin, a world-renown nephrologist and author of over 200 published pieces of research, Dr. Raymond Hakim, and former US Senator Bill Frist M.D., a retired cardiac surgeon and recognized leader for improving the quality of care provided to human beings across the world. We welcome all stakeholders in the CKD | ESRD ecosystem to join us in our mission to measurably improve outcomes for individuals living with these conditions.

keywords:N/A

$172M

Total Funding

561

Number of Employees

$192.4M

Revenue (est)

14%

Employee Growth %

N/A

Valuation

N/A

Accelerator

Monogram Health News

2022-04-17 - Dr Stephen Schleicher Previews Nashville IVBM Meeting

Stephen M. Schleicher, MD, MBA, chief medical officer, ... Monogram [Health] is also a Frist Cressey investor to OneOncology.

2022-04-06 - Medicare's aggressive approach to CKD attracts providers, value ...

Leslie Wong, MD, chief medical officer for Nephrology Care ... Care at home is the preferred option advocated by Monogram Health for...

2021-08-10 - Monogram Health Expands Leadership Team, Names General Counsel

NASHVILLE, Tenn., Aug. 10, 2021 /PRNewswire/ -- Monogram Health today announced Shawn L. Verner, J.D., has joined its leadership team as general counsel and chief compliance officer. Verner brings two decades of experience in health care law, policy, and compliance to the rapidly growing kidne ...

2021-06-08 - Monogram Health Closes $160M Series B Funding to Fuel Acceleration of Next Generation Kidney Care Model

NASHVILLE, Tenn., June 8, 2021 /PRNewswire/ -- Monogram Health, a benefit management and care delivery company transforming care for individuals with chronic kidney and end-stage renal disease, today announced that it has closed a $160 million Series B funding round led by TPG Capital, the pri ...

2021-06-08 - Monogram Health Raises $160M in Series B Funding

Monogram Health, a Nashville TN-based kidney disease benefit management and care delivery company, raised $160M in Series B funding. The round was led by TPG Capital, the private equity platform of global alternative asset firm TPG, with participation from existing investors Frist Cressey Ventu ...

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$191M566-3%N/A
#2
$104.2M57535%N/A
#3
$197.8M5866%N/A
#4
$35M5945%N/A
#5
$112.1M5988%N/A